The 2-Minute Rule for Healthcare News
Novo CEO pressed by Senate to chop costs of obesity, diabetic issues medicines CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would think about new talks with insurers in regards to the record selling prices of Wegovy and copyright should they pledge to help keep the medicines on their own formularies.Previously this summer time,